YU43499A - Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline - Google Patents

Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline

Info

Publication number
YU43499A
YU43499A YU43499A YU43499A YU43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A
Authority
YU
Yugoslavia
Prior art keywords
sodium salt
phenylpyrrolidin
indole
dichloro
oxo
Prior art date
Application number
YU43499A
Other languages
English (en)
Inventor
Zadeo Cimarosti
Paolo Maragni
Original Assignee
Glaxo Wellcome S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome S.P.A. filed Critical Glaxo Wellcome S.P.A.
Publication of YU43499A publication Critical patent/YU43499A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Kristalna hidratovana natrijumova so (E)-4,6-dihloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline Ovaj pronalazak odnosi se na natrijumovu so jedinjenja formule (1), na postupak za njeno pripremanje, i na njenu primenu u terapiji.
YU43499A 1997-03-05 1998-03-03 Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline YU43499A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
YU43499A true YU43499A (sh) 2000-12-28

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
YU43499A YU43499A (sh) 1997-03-05 1998-03-03 Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline

Country Status (29)

Country Link
EP (1) EP0966463A1 (sh)
JP (1) JP2001513796A (sh)
KR (1) KR20000075907A (sh)
CN (1) CN1249750A (sh)
AP (1) AP9901637A0 (sh)
AR (1) AR011178A1 (sh)
AU (1) AU6825198A (sh)
BG (1) BG103779A (sh)
BR (1) BR9808305A (sh)
CA (1) CA2282851A1 (sh)
CO (1) CO4940415A1 (sh)
EA (1) EA199900710A1 (sh)
EE (1) EE9900387A (sh)
GB (1) GB9704498D0 (sh)
HR (1) HRP980114A2 (sh)
HU (1) HUP0002109A2 (sh)
ID (1) ID24207A (sh)
IL (1) IL131489A0 (sh)
IS (1) IS5166A (sh)
NO (1) NO994303L (sh)
NZ (1) NZ337315A (sh)
OA (1) OA11154A (sh)
PE (1) PE51399A1 (sh)
PL (1) PL335652A1 (sh)
SK (1) SK119699A3 (sh)
TR (1) TR199902117T2 (sh)
WO (1) WO1998039327A1 (sh)
YU (1) YU43499A (sh)
ZA (1) ZA981791B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
BR9808305A (pt) 2000-05-16
CO4940415A1 (es) 2000-07-24
KR20000075907A (ko) 2000-12-26
EP0966463A1 (en) 1999-12-29
WO1998039327A1 (en) 1998-09-11
NO994303L (no) 1999-11-03
EA199900710A1 (ru) 2000-04-24
GB9704498D0 (en) 1997-04-23
PL335652A1 (en) 2000-05-08
ZA981791B (en) 1999-09-03
AP9901637A0 (en) 1999-09-30
CA2282851A1 (en) 1998-09-11
PE51399A1 (es) 1999-06-07
SK119699A3 (en) 2000-05-16
AR011178A1 (es) 2000-08-02
NZ337315A (en) 2001-02-23
HRP980114A2 (en) 1998-12-31
AU6825198A (en) 1998-09-22
HUP0002109A2 (hu) 2001-04-28
TR199902117T2 (xx) 2000-03-21
IL131489A0 (en) 2001-01-28
OA11154A (en) 2003-04-16
EE9900387A (et) 2000-04-17
NO994303D0 (no) 1999-09-03
CN1249750A (zh) 2000-04-05
IS5166A (is) 1999-08-27
JP2001513796A (ja) 2001-09-04
ID24207A (id) 2000-07-13
BG103779A (en) 2000-06-30

Similar Documents

Publication Publication Date Title
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
YU35697A (sh) Supstituisani 6,6-hetero-biciklični derivati
DK0544819T3 (da) Indolderivater, som inhiberer leukotrienbiosyntese
TR200201668T2 (tr) Vla-4' e bağlı hücre bağlamasının peptidilsiz önleyicileri
CA2260337A1 (en) Therapeutic agents
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
AU4831899A (en) 5-HT1F agonists
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
GB9514518D0 (en) Guanidine salt inhibitors of NO synthase and cyclooxygenase
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
AU2135695A (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
BR9509970A (pt) Composto
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
YU43499A (sh) Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
AU562643B2 (en) N-arylpiperazine derivatives
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
TR200003570T2 (tr) Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider